BeiGene | A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLC

A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous Non-small Cell Lung Cancer

Beigene Study ID

BGB-A317-304

ClinicalTrials.gov ID

NCT03663205

China Drug Trials ID

CTR20180032

Sex: All

Age: 18 Years / 75 Years

Study Protocol Statistical Analysis Plan

Sex: All

Age: 18 Years / 75 Years

Study Protocol Statistical Analysis Plan